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Edited by Frances ShannonAbstract The lipoxygenase pathway of immunocompetent cells
has been related to HIV infection and interleukins-4 and -13
have been described as major regulators of this metabolic route.
To explore whether 15-lipoxygenase1 expression might impact
the responsiveness of monocytic cells for HIV we induced expres-
sion of this enzyme by two independent ways (stable transfection
of U937 cells and culturing of blood monocytes in vitro in the
presence of granulocyte/monocyte colony stimulating factor
and interleukin 4) and assayed the cellular content of the two
HIV-1 receptors CD4 and CXCR4 (CD184) by real time RT-
PCR and ﬂuorescence-activated cell sorting. Wild-type U937
cells express CD4 and CXCR4 at high levels and expression
was not altered when the cells were transfected with control
plasmids. In contrast, expression of these proteins was strongly
reduced when the cells were stably transfected with 15-lipoxyge-
nase1. Similar eﬀects were observed when blood monocytes were
cultured in the presence of granulocyte/monocyte colony stimu-
lating factor and interleukin-4. Under these conditions strong
overexpression of 15-lipoxygenase1 was paralleled by downregu-
lation of CD4 and CXCR4. Since these surface proteins are
essential for the binding of T-tropic HIV-1 strains expression
of 15-lipoxygenase1 may confer resistance against HIV infection
to monocytic cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Infection with the human immunodeﬁciency virus (HIV) re-
sults in the development of acquired immunodeﬁciency syn-
drome (AIDS) [1]. The major targets for HIV-1 are cells
expressing CD4, mainly T-lymphocytes but also cells of mye-
loid lineage [2]. In addition to CD4, two major co-receptors
are required for HIV-1 entry, the a-chemokine receptor che-
mokine (C-X-C motif), receptor 4 (CXCR4) and/or the b-
chemokine receptor CCR5. CCR5 constitutes the major
co-receptor for M-tropic HIV-1 strains (R5) [3] whereasAbbreviations: LOX, lipoxygenase; CXCR4, chemokine (C-X-C mo-
tif), receptor 4; CCR5, chemokine (C-C motif) receptor 5; GAPDH,
glycerolaldehyde-3-phosphate dehydrogenase; PBS, phosphate buf-
fered saline; FACS, ﬂuorescence-activated cell sorting
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doi:10.1016/j.febslet.2005.05.054CXCR4 facilitates entry of T-tropic strains (X4) [4]. However,
some primary HIV-1 isolates are dual-tropic [5] and can infect
CCR5- and CXCR4-expressing cells. The two HIV co-recep-
tors CCR5 and CXCR4 belong to a heterogeneous family of
seven transmembrane G-protein coupled chemokine receptors
and their natural ligands are key players in recruitment of im-
mune cells to inﬂammatory sites [6]. Expression of HIV-1
receptors in host cells is regulated by various cytokines [7,8].
Interleukin-13 (IL13) has also been related to HIV-1 infection.
Progressive HIV infection in vivo is associated with decreased
plasma levels of IL13 [9] and highly active anti-retroviral ther-
apy in combination with IL2 administration appears to in-
crease the plasma concentrations of this cytokine [10]. In
various cell types IL13 downregulates expression of HIV-1
receptors (CD4 [11], CCR5 [12] and CXCR4 [13]) and viral
peptide constructs (gp41) impair the release of IL13 from baso-
phils [14]. IL13 constitutes a pleiotropic Th2 cytokine that
share many biological activities with IL4 [15]. Both cytokines
induce similar alterations in the gene expression pattern of
monocytic cells. In human peripheral monocytes, IL4 and
IL13 strongly upregulated expression of 15-LOX1 [16,17].
The mechanism of this process involves phosphorylation of
Interleukin 4/13 receptor components [18] and requires p38
MAP-kinase mediated phosphorylation of various STAT tran-
scription factors [19].
CXCR4 and CCR5 are the two major co-receptors for cellu-
lar entry HIV-1. Since IL13 downregulates expression of these
proteins [11,13] the question arose of whether or not IL13-in-
duced expression of 15-LOX1 might be involved in expression
regulation of HIV receptors. To investigate this question, we
induced 15-LOX1 overexpression in monocytic cells (U937
cells and blood monocytes) by two independent ways and
quantiﬁed expression of HIV-1 receptors CD4 and CXCR4
by real-time PCR and ﬂuorescence activated cell sorting
(FACS).2. Materials and methods
2.1. Chemicals
The origin of the chemicals used for RT-PCR is speciﬁed in [17].
Fluorescein isothiocyanate-conjugated mouse anti-human CD4 (clone
RPA-T4) and PE-conjugated mouse anti-human CD184 (clone 12G5)
from Becton Dickinson Biosciences (Heidelberg, Germany).
2.2. Cells and culture conditions
U937 cells (promyelomonocytic) were purchased from the German
Tissue and Cell Culture Collection (Braunschjweig, Germany) and cul-
tured according to the recommendation of the vendor. Human periph-
eral monocytes were prepared from the blood of healthy volunteersblished by Elsevier B.V. All rights reserved.
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cultured for 7 days in the presence of GM-CSF (100 ng/ml) and IL4
(50 ng/ml) [20].2.3. Semi-quantitative RT-PCR
RNA isolation and semi-quantitative RT-PCR were performed as
described previously [17] and the following primer combinations were
used. Glycerolaldehyde-3-phosphate dehydrogenase (GAPDH) (5 0-
CCA TCA CCA TCT TCC AGG AGC GA-3 0, upstream, 5 0-GGA
TGA CCT TGC CCA CAG CCT TG-3 0, downstream), size of product
447 bp; CD4 (5 0-AGA GCC TGA CCC TGA CCT TGG-3 0, up-
stream, 5 0-GCG AGT GGG AAG GAG AAC TCC-3 0, downstream),
size of PCR product 268 bp; CXCR4 (5 0-CAA GGG CCA CCA GAA
GCG CAA-3 0, upstream, 5 0-TTT GGA GAG GAT CTT GAG GCT
GGA-3 0, downstream), size of product 307 bp; CCR5 (5 0-TGA GAA
GAA GAG GCA CAG GGC TG-3 0, upstream, 5 0-GTG GAT CGG
GTG TAA ACT GAG CTT-3 0, downstream), size of PCR product
351 bp; and rabbit 15LOX1 (5 0-TGG CTG CCC CGC TGG TCA
TG-3 0, upstream, 5 0-CCT GGC GCG GAC GTT GAT CTC-3 0,
downstream), size of product 326 bp.2.4. Real-time PCR
The real-time PCR was carried out on a Rotor Gene 3000 instru-
ment (Corbett Res., Mortlake, Australia) using the QuantiTect SYBR
Green PCR Kit from Qiagen (Hilden, Germany). The primers used
were the same as for semi-quantitative RT-PCR and the protocol is
speciﬁed in [17].Fig. 1. Expression of various gene products in genetically modiﬁed
U937 cells (RT-PCR). Total RNA was extracted from wild-type and
genetically modiﬁed U937 cells (15-LOX1-transfectants, mock-trans-
fectants) and RT-PCR was carried out as described in Section 2. (A)2.5. Fluorescence-activated cell sorting (FACS)
To quantify the expression of CD4 and CXCR4 protein the cells
were washed with cold phosphate buﬀered saline (PBS) containing
0.25% EDTA, and stained with the corresponding antibodies for
45 min at 4 C. Then cells were washed two times with PBS, ﬁxed
and analyzed with a FACS Calibur cell sorter (Becton, Dickinson,
USA).15-LOX1 mRNA expression. (B) Expression of CD4, CCR5 and
CXCR4 mRNA.3. Results and discussion
To test the impact of 15-LOX1 expression on the expression
of co-receptors for T-trophic HIV-1 we selected U937 cells
since they express both CD4 and CXCR4 at high levels. In
contrast, CCR5 (co-receptor for M-trophic HIV-1 strains) is
only expressed in small amounts. Under our experimental con-
ditions, we quantiﬁed 206125 copies of CD4 transcripts and
456161 copies of CXCR4 transcripts per 106 GAPDH copies
for wild-type U937 cells. In contrast, only 25497 copies of
CCR5 transcripts per 106 GAPDH copies were detected. It
has been reported before that wild-type U937 cells do not ex-
press 15-LOX1 and we conﬁrmed these data in our study (not
shown). To explore whether induction of 15-LOX1 may alter
expression of T-tropic HVI-1 receptors (CD4 and CXCR4)
we stably transfect U937 cells with the rabbit 15-LOX1. RT-
PCR data and activity assays indicated that the 15-LOX1
transfectants expressed the enzyme at moderate levels [17]. In
contrast, the corresponding mock-transfectants did not express
the enzyme (Fig. 1A). Next, we analyzed RNA extracts of
wild-type U937 cells, 15-LOX1 transfectants and of mock-con-
trols for the presence of CD4, CXCR4 and CCR5 mRNA.
From Fig. 1B it can be seen that, on the mRNA level, wild-
type cells and the mock-transfectants express both, CD4 and
CXCR4 but not CCR5. Interestingly, CD4 and CXCR4
mRNA was virtually undetectable in 15-LOX1-transfected
cells. More quantitative real time PCR indicated the following
relative expression levels: Wild-type cells – 206125 copies of
CD4 mRNA per 106 GAPDH copies and 456161 copies ofCXCR4 mRNA per 106 GAPDH mRNA copies; mock-trans-
fected cells – 219538 copies of CD4 mRNA per 106 GAPDH
copies and 446206 copies of CXCR4 mRNA per 106 GAPDH
copies; 15-LOX1 transfected cells – 18026 copies of CD4
mRNA per 106 GAPDH copies and 26148 copies of CXCR4
mRNA per 106 GAPDH copies. These results were quiet sur-
prising since they suggested that expression of the 15-LOX1
may render U937 cells less susceptible for HIV-1 infection. It
was of particular importance that the numbers of CD4 and
CXCR4 transcripts were comparable for wild-type and
mock-transfected cells since these data exclude transfection
artifacts.
To conﬁrm these results on the protein level we performed
ﬂuorescence-activated cell sorting (FACS). From Fig.
2A,B,D it can be seen that wild-type and mock-transfected
U937 cells strongly express the CD4 surface antigen. In con-
trast, in the 15-LOX transfectants expression of this protein
was minimal as indicated by almost exact matching of the his-
tograms obtained for stained and unstained cells (Fig. 2C and
D). Similar results were obtained when a CXCR4-speciﬁc anti-
body was used for FACS analysis (Fig. 2E).
For independent evidence on the regulatory importance of
15-LOX1 for expression of CD4 and CXCR4 we employed a
second cellular system. Human peripheral monocytes do not
express 15-LOX1. However, strong induction of the enzyme
is observed when the cells are diﬀerentiated in vitro to dendritic
Fig. 2. Expression of T-trophic HIV-1 receptors in genetically modiﬁed U937 cells (FACS analysis). FACS analysis was performed as described in
material and methods. Grey areas indicate control measurements (non-immune serum). Upper panels: Fluorescence labeling using an anti-CD4
antibody – (A) wild-type U937 cells, (B) mock transfectants, (C) 15-LOX transfectants. Lower panels: (D) Overlay of the histograms obtained with
the anti-CD4 antibody, (E) Overlay of the histograms obtained with the anti-CXCR4 antibody.
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CSF and IL4 [20]. When human monocytes were cultured for
7 days in the presence of GM-CSF (100 ng/ml) and IL4 (50 ng/
ml) we observed strong upregulation of 15-LOX1 but gradual
downregulation of CD4, CXCR4 and CCR5 mRNA expres-
sion. The following experimental data were obtained: Absence
of IL4 – 7317 copies of 15-LOX1mRNA per 106 GAPDH tran-
scripts; 223026 copies of CD4 mRNA per 106 GAPDH tran-
scripts; 517462 copies of CXCR4 mRNA per 106 GAPDH
transcripts; 268613 copies of CCR5 mRNA per 106 GAPDH
transcripts. Presence of IL4 – 678598 copies of 15-LOX1mRNA
per 106 GAPDH transcripts; 189307 copies of CD4 mRNA per
106 GAPDH transcripts; 236046 copies of CXCR4 mRNA per
106GAPDHtranscripts; 160181 copies ofCCR5mRNAper 106
GAPDH transcripts.
The mechanism of downregulation of CD4 and CXCR4
expression in 15-LOX1 transfected U937 cells remains to be
investigated. Since LOXs are lipid peroxidizing enzymes [21]
their catalytic activity augments the intracellular peroxide con-
centrations [22] and this may impact expression of redox sensi-
tive genes [23]. When we incubated wild-type U937 cells in PBS
with hydrogen peroxide (10–100 lM) we observed reduction of
CD4 (75%) and CXCR4 (16%) expression by real time PCR.
Inversely, when our 15-LOX transfectants were cultured in
the presence of 1 mM of pyrrolidine dithiocarbamate (antioxi-
dant) expression of CRCX4 was twice as high (185 %) when
compared with control cells. These preliminary data suggest
that 15-LOX1 dependent modiﬁcation of the intercellular re-
dox state may contribute to impair HIV-1 susceptibility of
U937 cells. However, there may be alternative mechanisms.
15-LOX products have been identiﬁed as co-activators of per-
oxisome proliferator-activated receptors (PPAR) [24,25] and
stimulation of PPAR-a and PPAR-c slows down HIV-1 repli-
cation in acutely infected primary blood cells and in chronically
infected U1 cells [26]. Although the mechanisms of these eﬀects
have not been studied in detail it might be speculated that
expression regulation of HIV-1 receptors may be involved.Acknowledgements: This work was supported in part by research
grants of Deutsche Forschungsgemeinschaft (Ku 961/8-1) and the
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